Illumina investors voted chairman John Thompson off the board of directors on Thursday as Carl Icahn's months-long battle against the $32 billion gene-sequencing equipment maker crossed the finish line at the company's annual meeting. Why it matters: Icahn's proxy fight has pushed a seasoned…
#illumina #johnthompson #carlicahn #icahn #andrewteno #thompson #symantec #francisdesouza #robertepstein #teno
Continue reading...